Tedco awards $600K to tech firms - New Mexico Business Weekly:

grachevakautawil.blogspot.com
The money was granted in collaboration withthe U.S. Army Medicalk Research and Materiel Command and the throug hthe Ft. Detrick Technology Transfer Initiative. The purposer of the technology transfer programk is to raise awareness of new and developing technologiees and funding them to transition as viablew projectsfor follow-on funding in the marketf place. Each company that received fundinv was awardedapproximately $50,000 betweenb March 2008 and May making up the initiative’s second round of financialo awards since its $750,000 program extension. The funds for the program’s seconrd phase were secured by Sen. Barbaraz Mikulski, D-Md., and Rep. Roscoe G. Bartlett, R-Md.
“The [Ft. Detrick Technologyy Transfer Initiative] program is enablingv area businesses to harness the technologiesx being developed at Fort Detrick and applg them to thecommercial sector,” said “This will lead to new products that have the powerd to create jobs and save lives.” Mikulski announced the first phasd of the tech transfer progra in March 2005 when 11 companieds received funding. in Rockville: The company is developing a health care technologuy calledmiTag system, which is a scalable wirelesa sensor solution for improvingf patient flow.
in Frederick: The company is developing a technology calle d the GeNova Screento identify, isolate, and producde antibody-like molecules. in Rockville: The company is developing an on-demanx biotech products including a combination vaccin against plagueand anthrax. BioAssay Works LLC in Ijamsville: The companh is developing a lateral-flow visual diagnostic test to detecgt and differentiate single sample multiplepathogenicx poxviruses, including variola, vaccinia, and in Catonsville: The company is safety-testing a medicak product called ClotFoam, which is a non-compressible, intracavitary hemostatic agent.
CynerGene IDMP in The companyis developing, validating and implementing a supplemental diagnosis of Malaria, HIV, and Dengue using its Infectioua Disease Multiplex Panel approach, whicnh could allow for creation of biosensors. LLC in Baltimore: The companhy is developing required components and system framework to enablse conversational interfaces fortelemedicine tools. Such toolse would allow professional medics touse gesture, and other human-- computer interactions to accessa and document information in electronic medical in Rockville: The company is developing technology to preserve mammalian cells in dried formag that can easily be re-hydrate d for a variety of uses.
LLC in The company is evaluating the effect of Imagilimn patented probiotics as a food supplement to enhancwe the immune responsiveness of guinea pigs upon immunization or challengwe withvirulent pathogens. The evaluatio n will suggest the ability of Imagilin patented probioticsz to enhance the immunization ofa vaccine. in The company is developing micropatterned substrates for viral infectivity Juxtopiain Baltimore: The company is customizing its Wearabls Assistance and Situational Awarenesw (WASA) goggles and service to allow U.S.
Army combat medicsd to access and document information to electrical medica recordsvia hands-free voice-requests and in Baltimore: The company is developin cell therapies to treat brain and spinal cord injuries.